nach oben

Reactions Weekly

Erschienen in:

01.06.2023 | Case report

Belimumab

Various toxicities following in-utero exposure: 15 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Petri M, et al. Belimumab use during pregnancy: A summary of birth defects and pregnancy loss from belimumab clinical trials, et al. pregnancy registry and postmarketing reports. Annals of the Rheumatic Diseases 82: 217-225, No. 2, et al. Oct 2022. Available from: URL: http://ard.bmj.com/

Titel: Belimumab
Various toxicities following in-utero exposure: 15 case reports
Publikationsdatum: 01.06.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-41355-8

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Belimumab

Various toxicities following in-utero exposure: 15 case reports

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Baricitinib

Amitriptyline/duloxetine/gabapentin

Adverse events after use of compounded semaglutide

Severe-acute-respiratory-syndrome-coronavirus-2-mRNA-vaccine

Aciclovir

Levothyroxine-sodium